• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: OGDEN MANUFACTURING PLANT OPTIFLUX F250NRE HF 12/CS 2.5SA EBEAM; DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

OGDEN MANUFACTURING PLANT OPTIFLUX F250NRE HF 12/CS 2.5SA EBEAM; DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM Back to Search Results
Catalog Number 0500325E
Medical Device Problem Code Fluid/Blood Leak (1250)
Health Effect - Clinical Code Hemorrhage/Blood Loss/Bleeding (1888)
Date of Event 04/28/2026
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
Plant investigation: the plant investigation is in process.A supplemental mdr will be submitted upon completion of this activity.
 
Event or Problem Description
A user facility inventory manager reported a dialyzer blood leak.The estimated blood loss (ebl) was unknown.The sample was available to be returned for evaluation.Additional information was requested but was not received to date.
 
Additional Manufacturer Narrative
Additional information: a1, a2, a3, a4, b5, d10 concomitant medical product and therapy date codes, h6 device component code.
 
Event or Problem Description
A user facility inventory manager reported a dialyzer blood leak.The sample was available to be returned for evaluation.Upon follow-up, the clinic manager (cm) stated an external dialyzer blood leak occurred one hour and twenty minutes after initiation of hemodialysis (hd) treatment.The machine, a 2008t, did not alarm as the blood leak was external.The blood leak was visually observed at the dialyzer head.Blood was noted dripping from the clear top of plastic case of the dialyzer, and some small droplets of blood was noted on floor beneath the dialyzer and on the floor.Blood test strips were not used.The patient was utilizing fresenius bloodlines.No damage was noted on the dialyzer prior to treatment.The patient's blood was reportedly returned.The estimated blood loss (ebl) was not provided as the cm reported only two small droplets on the floor beneath the dialyzer was observed.Immediately following the event, the patient was re-setup with new supplies on the same machine and completed treatment without further issue.The machine is back in service.There was no patient injury, no adverse effects were experienced, and no medical intervention was required as a result of the reported event.The dialyzer was available to be returned for manufacturer evaluation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OPTIFLUX F250NRE HF 12/CS 2.5SA EBEAM
Common Device Name
DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM
Manufacturer (Section D)
OGDEN MANUFACTURING PLANT
director, site quality
475 west 13th street
ogden UT 84404
Manufacturer (Section G)
OGDEN MANUFACTURING PLANT
director, site quality
475 west 13th street
ogden UT 84404
Manufacturer Contact
jessica trujillo
920 winter st
waltham, MA 02451
6174175172
MDR Report Key25176272
Report Number0001713747-2026-00199
Device Sequence Number16070763
Product Code KDI
UDI-Device Identifier00840861100170
UDI-Public00840861100170
Combination Product (Y/N)N
Initial Reporter CountryUS
PMA/510(K) Number
K162488
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Health Professional,User Facility
Initial Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup,Followup
Report Date (Section B) 06/11/2026
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Other
Device Catalogue Number0500325E
Device Lot Number25NU04011
Was Device Available for Evaluation? No
Device AgeMO
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 05/06/2026
Supplement Date Received by Manufacturer05/19/2026
06/10/2026
Initial Report FDA Received Date05/14/2026
Supplement Report FDA Received Date05/20/2026
06/11/2026
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured10/16/2025
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
FRESENIUS 2008T MACHINE; FRESENIUS 2008T MACHINE; FRESENIUS BLOODLINES; FRESENIUS BLOODLINES
Patient Age70 YR
Patient SexMale
Patient Weight100 KG
-
-